Misonidazole is a radiosensitizer that was investigated in clinical trials.

It was used in these trials for radiation therapy to cause normally resistant hypoxic tumor cells to become sensitive to the treatment.

[1][2]

This antineoplastic or immunomodulatory drug article is a stub.

You can help Wikipedia by expanding it.